Abstract:Non‐alcoholic fatty liver disease (NAFLD) is an essential component of metabolic syndrome. Much evidence has demonstrated that the incidence of NAFLD is markedly increased in obese populations. In addition, adiposity and inflammation are two factors that critically contribute to the development and progression of hepatic steatosis and inflammatory damage in obesity‐associated NAFLD. While mediating the anti‐inflammatory activity of adenosine, the 2A receptor of adenosine (A2AR) also has a protective role in NAFLD. However, it remains largely unknown about the extent to which A2AR acts through altering adiposity vs. inflammation to protect against NAFLD. In the present study, the effects of A2AR deficiency on aspects of NAFLD were investigated in both obese mice and lean mice upon feeding wild‐type (WT) C57BL/6J mice and A2AR‐deficent mice a high‐fat diet (HFD) and/or a methionine‐ and choline‐deficient diet (MCD). Compared with low‐fat diet‐fed mice, HFD‐fed WT mice displayed overt hepatic steatosis and inflammation as indicated by increased proinflammatory signaling and cytokine expression. Furthermore, the severity of HFD‐induced hepatic steatosis and inflammation in A2AR‐deficient mice was much greater than that in WT mice, which was accompanied with increased body weight, adiposity, and adipose tissue infiltration of proinflammatory macrophages in HFD‐fed A2AR‐deficient mice. Unlike HFD‐fed mice, all MCD‐fed mice displayed lean phenotype due to a significant decrease in food intake. In the absence of adiposity, A2AR‐deficient mice still displayed a greater increase in the severity of hepatic steatosis and inflammation compared with WT mice. In an in vitro system, A2AR‐deficient macrophages showed an increase in proinflammatory responses compared with control cells. In addition, co‐culture of WT primary mouse hepatocytes with A2AR‐deficient macrophages caused significant increases in hepatocyte fat deposition and in hepatocyte proinflammatory responses compared with WT hepatocyte‐macrophage co‐cultures. Taken together, these results suggest that A2AR‐defiency‐associated inflammation is sufficient enough to bring about NAFLD aspects although A2AR deficiency can act through increasing both adiposity and inflammation to exacerbate NAFLD. Therefore, A2AR appears to protect against NAFLD mainly through its anti‐inflammatory activity.

P2Y2R Deficiency Ameliorates Hepatic Steatosis by Reducing Lipogenesis and Enhancing Fatty Acid β-Oxidation through AMPK and PGC-1α Induction in High-Fat Diet-Fed Mice

Niacin Ameliorates Hepatic Steatosis by Inhibiting De Novo Lipogenesis Via a GPR109A-Mediated PKC-ERK1/2-AMPK Signaling Pathway in C57BL/6 Mice Fed a High-Fat Diet

Terf2ip Deficiency Accelerates Non-Alcoholic Steatohepatitis Through Regulating Lipophagy and Fatty Acid Oxidation Via Sirt1/AMPK Pathway

P2Y13 receptor deficiency favors adipose tissue lipolysis and worsens insulin resistance and fatty liver disease

Peroxisome Proliferator-Activated Receptor Γ Coactivator 1α Maintains NAD+ Bioavailability Protecting Against Steatohepatitis

Genetic Deletion of Β2 Adrenergic Receptors Exacerbates Hepatocellular Lipid Accumulation in High-Fat Diet Mice.

Hepatocyte-specific Nrf2 Deficiency Mitigates High-Fat Diet-Induced Hepatic Steatosis: Involvement of Reduced PPARγ Expression

P2Y2R contributes to the development of diabetic nephropathy by inhibiting autophagy response

Deficiency of ADAR2 ameliorates metabolic-associated fatty liver disease via AMPK signaling pathways in obese mice

Exacerbation of NAFLD in Both HFD‐fed Mice and MCD‐fed Mice by Adenosine 2A Receptor Deficiency

The P2Y2 receptor mediates terminal adipocyte differentiation and insulin resistance: Evidence for a dual G-protein coupling mode

The Role of AMPKα2 in the HFD-induced Nonalcoholic Steatohepatitis.

Disruption of Adenosine 2A Receptor Exacerbates NAFLD Through Increasing Inflammatory Responses and SREBP1c Activity

RASAL2 Deficiency Attenuates Hepatic Steatosis by Promoting Hepatic VLDL Secretion Via the AKT/TET1/MTTP Axis

Role of adipose triglyceride lipase (PNPLA2) in protection from hepatic inflammation in mouse models of steatohepatitis and endotoxemia

PPARδ Attenuates Hepatic Steatosis Through Autophagy-Mediated Fatty Acid Oxidation

PAR2 promotes high-fat diet-induced hepatic steatosis by inhibiting AMPK-mediated autophagy

Rab2A regulates the progression of nonalcoholic fatty liver disease downstream of AMPK-TBC1D1 axis by stabilizing PPARγ

Ablation of Akt2 and AMPK α 2 rescues high fat diet-induced obesity and hepatic steatosis through Parkin-mediated mitophagy.

Extrahepatic PPARα modulates fatty acid oxidation and attenuates fasting-induced hepatosteatosis in mice

1705-P: Adipocyte Specific Ablation of P2Y14R Improves Glucose Metabolism in Mice with Diet-Induced Obesity